Pilot Study of Minocycline in Huntington's Disease

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Huntington Disease

In brief

This study is being conducted to assess the impact of minocycline on the progression of symptoms of HD. The study will also assess whether it is reasonable to continue with further study of minocycline in HD. We will measure the effect of minocycline on HD by measuring the change in Huntington's disease symptoms.

Key facts

Study ID
NCT00277355
Run by
Merit Cudkowicz
People needed
114
Starts
2006-04-01
Expected to finish
2008-11-01
Last updated by the study team
2013-04-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.